Clinical Trials in North Carolina

Showing 17561-17580 of 20,428 trials

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

NCT00583128

The objective of this study is to evaluate the safety and effectiveness of the experimental drug AST-120 in treating patients with non-constipating IBS. The study will test whether or not patients receiving AST-120 experience at least a 50% reduction in the number of days with abdominal pain compared to placebo.

Irritable Bowel Syndrome

Ocera Therapeutics117 participantsStarted Aug 2007

Huntsville, Alabama, United States • Sacramento, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 325 miles

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

NCT00808067

The purposes of this study are: 1. To evaluate the long-term safety of dabigatran etexilate 2. To assess the effect of a knowledge translation intervention on patient outcomes

Atrial Fibrillation

Boehringer Ingelheim5,897 participantsStarted Nov 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +564 more locations

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

Find Trials by Condition in North Carolina

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

Female Upper Genital Tract in HIV-infected Women

Enhancing the Prospective Prediction of Psychosis

Magnetic Seizure Therapy (MST) for the Treatment of Major Depression

Clinical Trial in Females for Female Pattern Hair Loss

Dapagliflozin DPPIV Inhibitor add-on Study

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

AST-120 Used to Treat Mild Hepatic Encephalopathy

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Biomarkers of Cockroach Sublingual Immunotherapy 2

A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

Effects of School Gardens on Children's Diet, Nutritional Knowledge, Etc.

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis